155 results
Page 2 of 8
S-4/A
rwgnvqw
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
rkwcu4
10 May 23
Registration of securities issued in business combination transactions
9:56pm
S-4
EX-10.23
g5vapz clzp8l9y9
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-99.2
hatqsw
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-99.2
yylxa4r0ac 1ckd8
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-10.1
0adlqtv30p ropqo
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
PRRN14A
bcoasunhbm
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
DEFA14A
EX-99.1
1rek9aa
5 Dec 22
Additional proxy soliciting materials
9:59pm
8-K
EX-99.1
kryj 5xp1l59
5 Dec 22
Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process
9:58pm
DEFC14A
s6r2o0q oqo
5 Dec 22
Proxy in contested solicitation
5:12pm
PRRN14A
99sb1 1hmpkbmu7
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm
PRER14A
cu7cmabmu
28 Nov 22
Preliminary revised proxy
5:17pm
PREC14A
ojqgl1ktl pxm54
23 Nov 22
Preliminary proxy with contested solicitation
11:26am
PREC14A
v7w1zk
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
8-K
EX-99.1
aga3i7lzk
18 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
4:40pm
DFAN14A
y7620 c6zlvu7a
18 Nov 22
Additional proxy materials by non-management
11:02am